Tectonic Therapeutic
TECX
92 hedge funds and large institutions have $135M invested in Tectonic Therapeutic in 2021 Q4 according to their latest regulatory filings, with 16 funds opening new positions, 24 increasing their positions, 43 reducing their positions, and 23 closing their positions.
14,200% more call options, than puts
Call options by funds: $572K | Put options by funds: $4K
1% more ownership
Funds ownership: 5.7% → 6.7% (+1%)
7% less funds holding
Funds holding: 99 → 92 (-7)
19% less capital invested
Capital invested by funds: $166M → $135M (-$31M)
30% less first-time investments, than exits
New positions opened: 16 | Existing positions closed: 23
44% less repeat investments, than reductions
Existing positions increased: 24 | Existing positions reduced: 43
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Goldman Sachs
New York
|
+$4.55M |
| 2 |
Janus Henderson Group
London,
United Kingdom
|
+$3.51M |
| 3 |
GC
GMT Capital
Atlanta,
Georgia
|
+$2.21M |
| 4 |
Acadian Asset Management
Boston,
Massachusetts
|
+$1.46M |
| 5 |
Federated Hermes
Pittsburgh,
Pennsylvania
|
+$991K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
CCM
Camber Capital Management
Boston,
Massachusetts
|
-$7.18M |
| 2 |
Citadel Advisors
Miami,
Florida
|
-$2.67M |
| 3 |
MB
MPM BioImpact
Boston,
Massachusetts
|
-$1.02M |
| 4 |
Millennium Management
New York
|
-$975K |
| 5 |
BlackRock
New York
|
-$758K |
TECX Hedge Fund Activity: Q4 2021 in Review
92 of the 6,498 institutional investors tracked by Wall St. Rank reported a position in Tectonic Therapeutic (TECX) for Q4 2021, worth a combined $135M — down 19% from $166M a quarter earlier.
Sellers outnumbered buyers: 23 funds closed out of TECX and 16 opened new positions — a net loss of 7 holders — while 43 trimmed existing stakes and 24 added.
The largest buyer was Goldman Sachs, adding an estimated $4.55M. The largest seller was Camber Capital Management, cutting an estimated $7.18M.
- 92 institutional investors held Tectonic Therapeutic (TECX) as of Q4 2021, down from 99 in Q3 2021.
- Funds reported $135M of Tectonic Therapeutic stock for Q4 2021, down 19% quarter-over-quarter.
- 16 funds opened new Tectonic Therapeutic positions in Q4 2021 and 23 closed out, a net change of -7 holders.
- The largest Tectonic Therapeutic buyer in Q4 2021 was Goldman Sachs, an estimated $4.55M added.
- The largest Tectonic Therapeutic seller in Q4 2021 was Camber Capital Management, an estimated $7.18M sold.
Based on aggregated 13F filings for Q4 2021.